講演・口頭発表等 - 森瀬 昌宏
-
6.EBUS-TBNAが診断に有用であった子宮頸癌肺転移の1例(第40回 日本呼吸器内視鏡学会中部支部会)
橋本 泉, 今井 直幸, 犬飼 朗博, 岩木 舞, 下方 智也, 森瀬 昌宏, 小川 知美, 山下 良, 田中 一大, 橋本 直純, 佐藤 光夫, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2011年 特定非営利活動法人 日本呼吸器内視鏡学会
-
Real-world evidence of crizotinib for ROS1-tested patients with non-small cell lung cancer in Japan 国際会議
Morise, M
ANNALS OF ONCOLOGY 2022年7月
-
Hase, T; Yanagisawa, K; Fukatsu, A; Kimura, T; Kojima, E; Abe, T; Imaizumi, K; Horio, Y; Oguri, T; Yamamoto, M; Ogasawara, T; Sugino, Y; Morise, M; Nakatochi, M; Ando, M; Kondo, M; Saka, H; Saito, H; Hasegawa, Y; Takahashi, T
JOURNAL OF CLINICAL ONCOLOGY 2020年5月20日
-
Tamiya, Y; Morise, M; Matsuzawa, R; Tanaka, I; Okada, T; Iwano, S; Hase, T; Hashimoto, N; Sato, M; Itoh, Y; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2019年10月
-
Koyama, J; Kimura, T; Oi, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kataoka, K; Matsuzawa, R; Fukihara, J; Sakamoto, K; Morise, M; Hashimoto, N; Kondoh, Y; Hasegawa, Y
ANNALS OF ONCOLOGY 2019年10月
-
Yanagitani, N; Takeuchi, S; Murayama, T; Yoshimura, K; Imai, Y; Takahara, S; Kawakami, T; Seto, T; Hattori, Y; Ohashi, K; Morise, M; Matsumoto, S; Yoh, K; Goto, K; Nishio, M; Yano, S
JOURNAL OF THORACIC ONCOLOGY 2019年10月
-
Hase, T; Morise, M; Taniguchi, H; Shindoh, J; Kojima, E; Tanikawa, Y; Suzuki, R; Ogasawara, T; Yamada, Y; Ando, M; Kondo, M; Saito, H; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2013年11月
-
PROGNOSTIC FACTORS IN RECURRENT SMALL-CELL LUNG CARCINOMA 国際会議
Morise, M; Mizutani, T; Oguri, T; Imai, N; Hase, T; Shindo, Y; Inukai, Y; Ito, S; Hashimoto, N; Sato, M; Kondo, M; Hasegawa, Y
ANNALS OF ONCOLOGY 2012年10月
-
Activity of tepotinib in brain metastases (BM): Preclinical models and clinical data from patients (pts) with MET exon 14 (METex14) skipping NSCLC 国際共著 国際会議
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M. C., Stanton T. S., Morise M., Lee J-S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P. K.
ANNALS OF ONCOLOGY 2020年9月
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) 国際会議
Yanagitani N., Takeuchi S., Murayama T., Yoshimura K., Imai Y., Takahara S., Kawakami T., Seto T., Hattori Y., Ohashi K., Morise M., Matsumoto S., Yoh K., Goto K., Nishio M., Yano S.
JOURNAL OF THORACIC ONCOLOGY 2019年10月
-
A nationwide genomic screening project for small cell lung cancer in Japan (LC-SCRUM-Japan) 国際会議
Daga Haruko, Umemura Shigeki, Ohe Yuichiro, Shiota Tetsuhiro, Fujita Masaki, Furuya Naoki, Tsuda Takeshi, Morise Masahiro, Matsumoto Shingo, Goto Koichi
ANNALS OF ONCOLOGY 2017年10月
-
Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping 国際共著 国際会議
Yang J. C-H., Le X., Cho B. C., Han J-Y., Morise M., Chen Y-M., Kang J-H., Kato T., Takeoka H., Chikamori K., Sakai H., Park K., Wu Y-L., Schumacher K., Bruns R., Straub J., Paik P.
ANNALS OF ONCOLOGY 2020年11月
-
Tepotinib Activity in Brain Metastases (BM): Preclinical Models and Clinical Data from MET Exon 14 (METex14) Skipping NSCLC 国際共著 国際会議
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M., Stanton T., Morise M., Lee J. -S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P.
JOURNAL OF THORACIC ONCOLOGY 2021年1月
-
Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy 国際会議
Hase T., Miyazaki M., Ichikawa K., Yogo N., Ozawa N., Ando M., Morise M., Sato M., Kondo M., Yamada K., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2018年10月
-
Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC 国際会議
Matsuzawa R., Morise M., Tanaka I., Koyama J., Kimura T., Kondoh Y., Hase T., Sakamoto K., Hashimoto N., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2019年10月
-
Risk Factor Evaluation of Programmed Death 1 Inhibitor Related Pneumonitis in Patients with Non-Small Cell Lung Cancer 国際会議
Fukihara J., Sakamoto K., Iwano S., Morise M., Hashimoto N., Hasegawa Y.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2018年
-
PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201). 国際会議
Hase Tetsunari, Yanagisawa Kiyoshi, Fukatsu Asuki, Kimura Tomoki, Kojima Eiji, Abe Takashi, Imaizumi Kazuyoshi, Horio Yoshitsugu, Oguri Tetsuya, Yamamoto Masashi, Ogasawara Tomohiko, Sugino Yasuteru, Morise Masahiro, Nakatochi Masahiro, Ando Masahiko, Kondo Masashi, Saka Hideo, Saito Hiroshi, Hasegawa Yoshinori, Takahashi Takashi
JOURNAL OF CLINICAL ONCOLOGY 2020年5月20日
-
Phase II study of tepotinib in NSCLC patients with METex14 mutations. 国際共著 国際会議
Paik Paul K., Veillon Remi, Cortot Alexis B., Felip Enriqueta, Sakai Hiroshi, Mazieres Julien, Griesinger Frank, Horn Leora, Senellart Helene, Van Meerbeeck Jan P., de Castro Carpeno Javier, Patel Jyoti D., Garassino Marina Chiara, Morise Masahiro, Reinmuth Niels, Viteri Santiago, Tokito Takaaki, Sakamoto Tomohiro, Scheele Juergen, Le Xiuning
JOURNAL OF CLINICAL ONCOLOGY 2019年5月20日
-
Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan). 国際会議
Udagawa Hibiki, Ikeda Takaya, Umemura Shigeki, Daga Haruko, Toyozawa Ryo, Harada Daijiro, Sakakibara-Konishi Jun, Morise Masahiro, Yamamoto Noboru, Takahashi Toshiaki, Kato Terufumi, Shingyoji Masato, Ushio Ryota, Hara Satoshi, Takata Saori, Nomura Shogo, Matsumoto Shingo, Niho Seiji, Sato Akihiro, Goto Koichi
JOURNAL OF CLINICAL ONCOLOGY 2020年5月20日
-
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study 国際会議
Shimokawa M., Nosaki K., Seto T., Ohashi K., Morise M., Fujiwara Y., Sakakibara J., Murakami H., Yano S., Satouchi M., Matsumoto S., Goto K., Yoh K.
ANNALS OF ONCOLOGY 2019年4月